Skip to main content

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Projects

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Daniel Martinez Gonzalez

Daniel Martinez Gonzalez

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Maria Antonia Perello Barcelo

Maria Antonia Perello Barcelo

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Carmen Rodriguez Fernandez

Carmen Rodriguez Fernandez

Research technician
Ophtalmology
Read more
Patricia Muñoz Cabello

Patricia Muñoz Cabello

Predoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.